BCR and chronic myelogenous leukemia, BCR-ABL1 positive: BCR/ABL-mediated signal transduction pathways could interfere with various cellular physiological processes, including cells proliferation, transformation, and apoptosis, which made the BCR/ABL kinase an attractive target for clinical intervention in CML [4, 5].